HIT Consultant May 17, 2024
Fred Pennic

What You Should Know:

Implicity, a leader in remote patient monitoring and cardiac data management, has received FDA 510(k) clearance for SignalHF1, a groundbreaking new algorithm within their remote monitoring solution.

– SignalHF1 algorithm empowers early detection and intervention, paving the way for improved patient outcomes and a brighter future for cardiac care.

Leveraging Big Data for Better Heart Care

Implicity holds a unique distinction as the first private company to access the Health Data Hub, a vast repository of patient data on heart disease. By combining this comprehensive database with data from their AI-powered platform, Implicity’s team developed and validated SignalHF1. This machine learning algorithm analyzes data to assess a patient’s risk of future heart failure...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Patient / Consumer, Provider, Technology
AI-Powered Digital Therapeutics Transform Neurocare for Parkinson's
Continuous Glucose Monitors Predict Type 1 Diabetes Complications
Intrinsic Value v Market Value in today's HealthTech M&A market
The Doctor Will See You… On Amazon: Tech Giant Expands Plans to Merge Medicine with Marketplace
Technology As A Healthcare Equalizer: Closing The Digital Divide

Share This Article